Reuters logo
2 个月前
BRIEF-Endo says reviewing FDA's request to withdraw Opana ER from market
2017年6月8日 / 晚上9点59分 / 2 个月前

BRIEF-Endo says reviewing FDA's request to withdraw Opana ER from market

June 8 (Reuters) - Endo International Plc:

* Endo response to june 8, 2017 FDA meeting related to opana® er

* Endo international plc- "endo is reviewing request and is evaluating full range of potential options as we determine appropriate path forward"

* Endo - fda's request to withdraw opana er from market does not indicate uncertainty with product's safety or efficacy when taken as prescribed Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below